Medfinder
Back to blog

Updated: April 9, 2026

Evenity Drug Interactions: What to Avoid and What to Tell Your Doctor

Author

Peter Daggett

Peter Daggett

Evenity blog post header image

Evenity (romosozumab) has important drug interactions, especially around osteonecrosis of the jaw risk. Know what to tell your doctor before starting in 2026.

Before starting Evenity (romosozumab), it's essential to give your healthcare provider a complete list of all medications, supplements, and herbal products you take. While Evenity doesn't have an extensive list of traditional pharmacokinetic drug interactions (where one drug affects the blood levels of another), it does have important interactions and combination risks that patients need to know about.

The Most Important Interaction: Osteonecrosis of the Jaw (ONJ) Risk with Certain Medications

The most clinically significant drug interaction concern with Evenity is the elevated risk of osteonecrosis of the jaw (ONJ) when combined with certain medication classes. ONJ is a serious condition where jawbone tissue loses blood supply and dies. While rare on Evenity alone, the risk increases substantially when combined with:

Bisphosphonates (alendronate/Fosamax, zoledronic acid/Reclast, ibandronate/Boniva, risedronate/Actonel): Concurrent use of bisphosphonates significantly elevates ONJ risk. Providers should avoid combining these medications with Evenity.

Denosumab (Prolia): Concurrent use elevates ONJ risk. Denosumab is commonly prescribed AFTER Evenity (as a sequencing strategy), but should not be used simultaneously.

Corticosteroids (prednisone, methylprednisolone, dexamethasone): Chronic corticosteroid use increases ONJ risk. Tell your doctor if you take steroids for conditions like asthma, rheumatoid arthritis, lupus, or inflammatory bowel disease.

Chemotherapy agents: Many cancer chemotherapy drugs increase ONJ risk. If you are receiving cancer treatment, discuss this with both your oncologist and the prescribing provider before starting Evenity.

Angiogenesis inhibitors (bevacizumab/Avastin, sunitinib/Sutent, sorafenib/Nexavar): These targeted cancer therapies affect blood vessel formation and significantly elevate ONJ risk when combined with bone-targeted therapies.

Cardiovascular Medications: Important Considerations

Evenity carries a boxed warning for increased cardiovascular risk (heart attack, stroke, cardiovascular death). While there are no specific drug-drug interactions that directly increase this cardiovascular risk further, you must inform your doctor about:

All cardiovascular medications you take (statins, beta-blockers, ACE inhibitors, anticoagulants)

Any antiplatelet drugs (aspirin, clopidogrel/Plavix) which may mask cardiovascular symptoms

Your complete cardiovascular history so your doctor can properly assess the benefit-risk of Evenity for you

Calcium and Vitamin D: Required Supplementation During Evenity

Evenity can lower blood calcium levels (hypocalcemia). Your doctor will require you to take calcium and vitamin D supplements during the 12-month treatment course. The specific doses depend on your dietary intake and baseline levels — follow your prescriber's specific recommendations. Adequate calcium and vitamin D supplementation is not optional; it's a safety requirement.

Medications That Can Affect Calcium Levels

Since Evenity can lower calcium, be especially careful about other medications that also lower calcium, including:

Loop diuretics (furosemide/Lasix) — increase urinary calcium excretion

Proton pump inhibitors (omeprazole, pantoprazole) — can reduce calcium absorption from diet

Anti-epileptic drugs (phenytoin, carbamazepine) — can affect vitamin D metabolism and calcium absorption

No Major Pharmacokinetic Drug-Drug Interactions Identified

The FDA prescribing information notes that no clinically significant pharmacokinetic differences in romosozumab exposure were observed based on age (20-89 years), sex, race, disease state, prior bisphosphonate exposure, or renal impairment including end-stage renal disease requiring dialysis. There are no documented interactions where another drug changes the blood levels of Evenity in a clinically meaningful way (or vice versa).

What to Tell Every Doctor and Dentist

Tell every healthcare provider you see that you are on Evenity, including:

Your dentist — especially before any tooth extractions, implants, or other oral surgery. ONJ risk in dental procedures is a key concern.

Your cardiologist — given the cardiovascular boxed warning.

Any specialist who prescribes cancer, rheumatology, or inflammatory disease medications.

For a full overview of Evenity's side effect profile, see our guide on Evenity side effects.

Frequently Asked Questions

No. Concurrent use of bisphosphonates (alendronate, zoledronic acid, ibandronate, risedronate) with Evenity significantly increases the risk of osteonecrosis of the jaw (ONJ). Bisphosphonates are commonly prescribed after completing Evenity as a sequencing strategy — not simultaneously with it.

Yes, in terms of ONJ risk. Concurrent use of denosumab (Prolia) and Evenity elevates the risk of osteonecrosis of the jaw. Denosumab is commonly prescribed after Evenity is completed (sequential therapy) to maintain bone density gains — but the two should not be used at the same time.

Yes — and it's required. Evenity can lower blood calcium levels, so adequate calcium and vitamin D supplementation is mandatory throughout the 12-month treatment course. Your doctor will specify the appropriate doses based on your dietary intake and serum calcium levels.

Discuss this with both your prescribing provider and your dentist. ONJ risk is associated with invasive dental procedures (extractions, implants). Your doctor and dentist will weigh the urgency of the dental procedure against the timing of your Evenity doses. Good oral hygiene and dental exams before starting Evenity are essential preventive steps.

There are no well-documented interactions between Evenity and common OTC supplements. However, tell your doctor about all supplements you take, especially those that affect bone or calcium metabolism (vitamin K2, magnesium, strontium) and fish oil/omega-3 supplements. Avoid supplements that affect cardiovascular risk since Evenity carries a cardiovascular boxed warning.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Evenity also looked for:

36,651 have already found their meds with Medfinder.

Start your search today.

36K+
5-star ratingTrusted by 36,651 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?